Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV003104126 | SCV001684105 | likely benign | Catecholaminergic polymorphic ventricular tachycardia 1 | 2020-02-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002439147 | SCV002749739 | uncertain significance | Cardiovascular phenotype | 2021-05-19 | criteria provided, single submitter | clinical testing | The c.279T>A variant (also known as p.V93V), located in coding exon 4 of the RYR2 gene, results from a T to A substitution at nucleotide position 279. This nucleotide substitution does not change the amino acid at codon 93. This nucleotide position is highly conserved in available vertebrate species. In silico splice site analysis for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
All of Us Research Program, |
RCV004804196 | SCV005426568 | likely benign | Catecholaminergic polymorphic ventricular tachycardia | 2024-08-13 | criteria provided, single submitter | clinical testing |